Get started
Author

Adélaïde Chesnay

Observed names: A Chesnay, A. Chesnay, Adelaide Chesnay, Adelaïde Chesnay, Chesnay, Adélaïde
Observed institutions: Université de Tours, Inserm, Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, Centre Hospitalier Universitaire d'Angers, Centre Hospitalier Andrée Rosemon, Centre d'Étude des Pathologies Respiratoires, Centre hospitalier universitaire de Guyane
ORCID: 0000-0001-6218-2442
Observed ORCID: 0000-0001-6218-2442
OpenAlex ID: A5036769962
Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018)
2022 · Stéphane Bretagne, Karine Sitbon, et al. · mBio · 115
Combination of β‐(1, 3)‐D‐glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia
2019 · Guillaume Desoubeaux, Adélaïde Chesnay, et al. · Mycoses · 35
PDF
Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model
2019 · David Chauvin, Michael Hust, et al. · Frontiers in Microbiology · 24
PDF
Advent of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis treatment: What consequences on Aspergillus-related diseases? Preliminary insights
2022 · Adélaïde Chesnay, Éric Bailly, et al. · Journal of Cystic Fibrosis · 20
Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) under managed care: a clinical and environmental investigation in a French zoological park
2022 · Estelle Cateau, Antoine Leclerc, et al. · Medical Mycology · 16
Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives
2021 · Alexie Mayor, Adélaïde Chesnay, et al. · Vaccines · 16
PDF
Case series of intestinal microsporidiosis in non-HIV patients caused by Encephalitozoon hellem
2023 · Céline Nourrisson, Samia Hamane, et al. · Emerging Microbes & Infections · 13
PDF
Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012–2022)
2025 · Thiziri Tala-Ighil, Dea Garcia-Hermoso, et al. · Clinical Infectious Diseases · 10
Demonstration of the yeasticidal efficacy of povidone-iodine–based commercial antiseptic solutions against Candida auris
2021 · Adélaïde Chesnay, Éric Bailly, et al. · Journal de Mycologie Médicale · 10
PDF
Candida nivariensis: Identification strategy in mycological laboratories
2020 · N. Cartier, A. Chesnay, et al. · Journal de Mycologie Médicale · 10
PDF
Discordance in the minimal inhibitory concentrations of ertapenem for Enterobacter cloacae: Vitek 2 system versus Etest and agar dilution methods
2013 · Hélène Pailhoriès, Viviane Cassisa, et al. · International Journal of Infectious Diseases · 10
Intricate isavuconazole therapy of a subcutaneous nodule caused by Alternaria infectoria in a heart transplant recipient
2021 · Valentin Maisons, Guillaume Desoubeaux, et al. · Journal de Mycologie Médicale · 9
PDF
Challenges to establish the diagnosis of aspergillosis in non-laboratory animals: looking for alternatives in veterinary medicine and demonstration of feasibility through two concrete examples in penguins and dolphins
2022 · Guillaume Desoubeaux, Carolyn Cray, et al. · Frontiers in Cellular and Infection Microbiology · 8
PDF
Health threat caused by fungi of medical interest: where are we in 2021?
2021 · Guillaume Desoubeaux, Adélaïde Chesnay · Frontiers in Bioscience-Landmark · 8
PDF
Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
2022 · Adélaïde Chesnay, Christophe Paget, et al. · Journal of Fungi · 7
PDF
Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia
2025 · Aubin Pitiot, Bianca Brandus, et al. · EBioMedicine · 6
Fumagillin Shortage: How to Treat Enterocytozoon bieneusi Microsporidiosis in Solid Organ Transplant Recipients in 2024?
2024 · Cyril Garrouste, Philippe Poirier, et al. · Transplant International · 6
PDF
Emerging therapeutics: The imidazo[1,2-b]pyridazine scaffold as a novel drug candidate for eumycetoma, a neglected tropical disease
2024 · Lamis Yahia Mohamed Elkheir, Pierre-Olivier Delaye, et al. · European Journal of Medicinal Chemistry · 6
Contribution of a molecular test for the diagnosis of genital infection with Trichomonas vaginalis and Mycoplasma genitalium
2020 · Adélaïde Chesnay, Benoit Lancelin, et al. · Annales de biologie clinique · 6
PDF
Approches diagnostiques des filarioses en France métropolitaine
2020 · Guillaume Desoubeaux, Adélaïde Chesnay, et al. · Revue Francophone des Laboratoires · 4
Description of a Murine Model of Pneumocystis Pneumonia
2024 · Adélaïde Chesnay, Loïc Gonzalez, et al. · Mycopathologia · 3
PDF
From strongyloidiasis to disseminated mucormycosis: the story of an HTLV-1-infected migrant
2020 · Brice Autier, Adélaïde Chesnay, et al. · Journal of Travel Medicine · 3
Yeast fungaemia among injection drug users in France (2012–2022): a cross-sectional observational study
2025 · Olivier Paccoud, Olivier Lortholary, et al. · The Lancet Regional Health - Europe · 2
PDF
Multiplex PCR assay targeting Trichomonas vaginalis: need for biological evaluation and interpretation
2022 · Adélaïde Chesnay, Adeline Pastuszka, et al. · Diagnostic Microbiology and Infectious Disease · 2
PDF
Antifungal exposure in Scedosporium septic arthritis: synovial penetration of voriconazole and terbinafine and plasma concentrations of olorofim
2026 · Chemsa Le Cœur, Olivier Le Tilly, et al. · Antimicrobial Agents and Chemotherapy · 1
PDF
Works count: 45
Citation count: 356
H-index: 10
I10-index: 11
Year
Topic
Type